Unsal Tan O, Vagolu SK, Tønjum T, Kaplan O, Simsek R(2025) Promising Antimycobacterial Agents: Salicylidenehydrazines Arch Pharm (Weinheim), 358(7), e70065 DOI 10.1002/ardp.70065, PubMed 40726231
Dwt N, Leon De La Fuente R, Gallo P, Naesgaard P, Dib Ashur S, Michelsen AE, Aukrust P, Staines H, Ueland T(2025) High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up Int J Cardiol, 439, 133674(in press) DOI 10.1016/j.ijcard.2025.133674, PubMed 40716679
Andersen T, Ueland T, Aukrust P, Nilsen DW, Grundt H, Staines H, Kontny F(2025) Correction: Podocan and adverse clinical outcome in patients admitted with suspected acute coronary syndromes Front Cardiovasc Med, 12, 1650098 DOI 10.3389/fcvm.2025.1650098, PubMed 40693227
